IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 6 39-6, 1999, Pages

  Schultz, Michael ^a,f   Tonkonogy, Susan L ^b   Sellon, Range K ^b   Veltkamp, Claudia ^a   Godfrey, Virginia L ^c   Kwon, Julie ^b   Grenther, Wetonia B ^b   Balish, Edward ^d   Horak, Ivan ^e   Sartor, R Balfour ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Animal models; Colitis; Interleukin 2 deficient mice; Luminal flora

Indexed keywords

INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL COLONIZATION; CELL DIFFERENTIATION; CYTOKINE RELEASE; ENTERITIS; GENETIC ENGINEERING; GERMFREE ANIMAL; HEPATITIS; INTESTINE FLORA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033000343     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.6.g1461     Document Type: Article

References (51)

1. Autenrieth, I. B., N. Bucheler, E. Bohn, G. Heinze, and I. Horak. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41: 793-800, 1997.
2. Axelsson, L.-G., T. Midtvedt, and A.-C. Bylund-Fellenius. The role of intestinal bacteria, bacterial translocation and endotoxin in dextran sodium sulphate-induced colitis in the mouse. Microb. Ecol. Health Disease 9: 225-237, 1996.
3. Banerjee, A. K., and T. J. Peters. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. Gut 31: 1358-1364, 1990.
4. Beckwith, C. S., C. L. Franklin, R. R. Hook, C. L. Besch-Williford, and L. K. Riley. Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents. J. Clin. Microbiol. 35: 1620-1623, 1997.
5. + Th1-like responses. J. Clin. Invest. 98: 1010-1020, 1996.
6. 3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159: 44-52, 1997.
7. Clarke, C. J., and C. R. Stokes. The intestinal and serum humoral immune response to systemically and orally administered antigens in liposomes. I. The response to liposome-entrapped soluble proteins. Vet. Immunol. Immunopathol. 32: 125-138, 1992.
8. Contractor, N. V., H. Bassiri, T. Reya, A. Y. Park, D. C. Baumgart, M. A. Wasik, S. G. Emerson, and S. R. Carding. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J. Immunol. 160: 385-394, 1998.
9. Davidson, N. J., S. A. Judak, R. E. Lesley, S. Menon, M. W. Leach, and D. Rennick. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10 deficient mice. J. Immunol. 161: 3143-3149, 1998.
10. Davis, S. W., L. C. Holt, and R. B. Sartor. Luminal bacteria and bacterial polymers potentiate indomethacin-induced intestinal injury in the rat (Abstract). Gastroenterology 100: A113, 1990.
11. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK 1. 5. Similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131: 2445-2451, 1983.
12. Dianda, C., A. M. Hanby, N. A. Wright, A. Sebesteny, A. C. Hayday, and M. J. Owen. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150: 91-97, 1997.
13. Duchmann, R., E. Schmitt, P. Knolle, K.-H. Mayer zum Büschenfeld, and M. Neurath. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26: 934-938, 1996.
14. Fuss, I. J., M. Neurath, M. Boirivant, J. S. Klein, C. de la Motte, S. A. Strong, C. Fiocchi, and W. Strober. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157: 1261-1270, 1996.
15. Jobin, C., H. H. Herfarth, and R. B. Sartor. Bacterial products and cytokines upregulate IL-8 gene expression in human colonic epithelial cell lines (Abstract). Gastroenterology 108: A844, 1995.
16. Jung, H. C., L. Eckmann, S.-K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M. F. Kagnoff. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95: 55-65, 1995.
17. Kono, K., K. Ohnishi, M. Omata, M. Saito, T. Nakayama, H. Hatano, Y. Nakajiama, S. Sugita, and K. Okuda. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 94: 787-796, 1988.
18. Krämer, S., A. Schimpl, and T. Hünig. Immunopathology of interleukin-2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182: 1769-1776, 1995.
19. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
20. Kündig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. Immune responses in IL-2-deficient mice. Science 262: 1059-1061, 1993.
21. Kuroe, K., Y. Haga, O. Funakoshi, I. Mizuki, K. Kanazawa, and Y. Yoshida. Rabbit granulomatous enterocolitis induced by injection of muramyl dipeptide emulsified with Freud's incomplete adjuvant. J. Gastroenterol. 30: 472-477, 1995.
22. Ledbetter, J. A., and L. A. Herzenberg. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 69: 5-23, 1982.
23. Lichtman, S. N., J. Keku, J. H. Schwab, and R. B. Sartor. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect. Immun. 59: 555-562, 1991.
24. Lichtman, S. N., R. B. Sartor, J. Keku, and J. H. Schwab. Hepatic inflammation in rats with experimental bacterial small intestinal overgrowth. Gastroenterology 98: 414-423, 1990.
25. Ma, A., M. W. Datta, E. Margosian, J. Chen, and I. Horak. T cells, but not B cells, are required for bowel inflammation in the interleukin-2-deficient mice. J. Exp. Med. 182: 1567-1572, 1995.
26. McCall, R. D., S. Haskill, E. M. Zimmermann, P. K. Lund, R. C. Thompson, and R. B. Sartor. Tissue IL-1 and IL-1 receptor antagonist expression in rat strains variably susceptible to granulomatous enterocolitis. Gastroenterology 106: 960-972, 1994.
27. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281-1290, 1995.
28. Paul, W. E., and R. A. Seder. Lymphocyte responses and cytokines. Cell 76: 241-251, 1994.
29. Pozzilli, P., A. Signore, A. J. Williams, and P. E. Beales. NOD mouse colonies around the world - recent facts and figures. Immunol. Today 14: 193-196, 1993.
30. 27/β2 microglobulin transgenic rats. J. Clin. Invest. 98: 945-953, 1996.
31. Rath, H. C., M. Schultz, L. A. Dieleman, F. Li, H. Kölbl, W. Falk, J. Schölmerich, and R. B. Sartor. Selective vs. broad spectrum antibiotics in the prevention and treatment of experimental colitis in two rodent models (Abstract). Gastroenterology 114: A1067, 1998.
32. Rath, H. C., M. Schultz, W. B. Grenther, K. H. Wilson, S. L. Tonkonogy, J. D. Taurog, R. E. Hammer, and R. B. Sartor. Colitis, gastritis and antibacterial lymphocyte responses in HLA-B27 transgenic rats monoassociated with Bacteroides vulgatus or Escherichia coli (Abstract). Gastroenterology 112: A1068, 1997.
33. Reis e Sousa, C. R., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. In vivo microbial stimulation induced rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186: 1819-1829, 1997.
34. Robert, A., and T. Asano. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 14: 333-341, 1977.
35. Sadlack, B., J. Löhler, H. Schorle, G. Klebb, H. Haber, E. Sickel, R. J. Noelle, and I. Horak. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25: 3053-3059, 1995.
36. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261, 1993.
37. Sartor, R. B. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In: Inflammatory Bowel Disease (4th Ed.), edited by J. B. Kirsner and R. G. Shorter. Baltimore, MD: Williams & Wilkins, 1995, p. 96-124.
38. Sartor, R. B. Review article: how relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment. Pharmacol. Ther. 11: 89-96, 1997.
39. Sartor, R. B., D. E. Bender, T. Grenther, and L. C. Holt. Absolute requirement for ubiquitous luminal bacteria in the pathogenesis of chronic intestinal inflammation (Abstract). Gastroenterology 106: A767, 1994.
40. Sartor, R. B., T. M. Bond, and J. H. Schwab. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect. Immun. 56: 2101-2108, 1988.
41. Schorle, H., T. Holtschke, T. Hünig, A. Schimpl, and I. Horak. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621-624, 1994.
42. Sellon, R. K., S. L. Tonkonogy, M. Schultz, L. A. Dielemann, W. Grenther, E. Balish, D. M. Rennick, and R. B. Sartor. Normal enteric bacteria are necessary for the development of spontaneous colitis and immune system activation in IL-10 deficient mice. Infect. Immun. 66: 5224-5231, 1998.
43. + T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol. 25: 2618-2625, 1995.
44. Simpson, S. J., S. Shah, M. Comiskey, Y. P. de Jong, B. Wang, E. Mizoguchi, A. K. Bhan, and C. Terhorst. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon-gamma expression by T cells. J. Exp. Med. 187: 1225-1234, 1998.
45. Stonerock, M. J., H. S. Weiss, J. V. Rodriguez, J. I. Hernandez, O. C. Peck, and J. D. Wood. Temperature-metabolism relations in the cotton-top tamarin (Sanguinus oedipus) model for ulcerative colitis. J. Med. Primatol. 23: 16-22, 1994.
46. Swain, S. L. Lymphokines and the immune response: the central role of interleukin-2. Curr. Opin. Immunol. 3: 304-310, 1991.
47. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, W. A. Zhou, J. L. Fernandez-Sueiro, E. Balish, and R. E. Hammer. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180: 2359-2364, 1994.
48. Tonkonogy, S. L., D. T. McKenzie, and S. L. Swain. Regulation of isotype production by IL-4 and IL-5: effects of lymphokines on Ig production depend on the state of activation of the responding B cells. J. Immunol. 142: 4351-4360, 1989.
49. Tonkonogy, S. L., and R. B. Sartor. Immune system activation in C3H/HeJBir mice exhibiting spontaneous perianal inflammation. Inflamm. Bowel Dis. 3: 10-19, 1997.
50. Yale, C. E., and E. Balish. Blood and serum chemistry values of gnotobiotic beagles. Lab. Anim. Sci. 26: 633-639, 1976.
51. Yamada, T., E. Deitch, R. A. Specian, M. A. Perry, R. B. Sartor, and M. B. Grisham. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17: 641-662, 1993.